Navigation Links
First Patient Enrolled in Therakos Phase Two Study for Treatment of Graft-versus-Host Disease
Date:12/6/2011

RARITAN, N.J., Dec. 6, 2011 /PRNewswire/ -- Therakos, Inc., a pioneer in the innovative treatment of extracorporeal photopheresis (ECP) for immune modulation therapy, today announced that the first patient has been enrolled in its Phase IIb clinical study evaluating the use of the company's photopheresis technology in the treatment of patients with moderate-to-severe chronic Graft-versus-Host Disease (GvHD). An estimated 15,000 new patients worldwide are diagnosed every year with chronic GvHD, a life threatening condition occurring when a donor's transplanted stem cells attack the recipient's body.(1)(2)

"In the United States, there is a significant need for improved Graft-versus-Host Disease treatments as current therapies aim to suppress the immune system and can be extremely harsh on an already compromised patient," said Dennis Parenti, M.D., Vice President of Clinical Affairs, Therakos. "We are very excited about this investigation of photopheresis for chronic GvHD patients."

The Therakos study will assess the safety and efficacy of ECP treatment as an add-on to the standard of care for patients suffering from moderate-to-severe GvHD. ECP is a therapeutic procedure performed outside the body using either the THERAKOS™ UVAR™ XTS™ Photopheresis System or the THERAKOS™ CELLEX™ Photopheresis System. Patients will be enrolled over an 18-month period. Randomization will occur in a 1:1 ratio with half of the patients receiving the current standard of care and the other half receiving standard of care coupled with ECP.

The initial patient was enrolled by Vikas Bhushan, M.D. at The Medical City Dallas Hospital in Texas who is serving as an investigator in the trial. Dr. Bhushan commented, "I am pleased to be a part of this unique prospective comparative study rigorously evaluating photopheresis in chronic Graft-versus-Host Disease. ECP has been utilized to treat many immu
'/>"/>

SOURCE Therakos, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Heart Hospital of Austin Physician First in Texas to Implant New Heart Failure Device
2. Mylan Receives Tentative FDA Approval Through PEPFAR for First Heat-Stable, Fixed-Dose Combination of Atazanavir Sulfate and Ritonavir Tablets for HIV/AIDS
3. Arbor Pharmaceuticals Announces Filing of First NDA
4. Mylan Confirms First-to-File Patent Challenge Relating to Generess™ Fe
5. Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in XIAFLEX® Study for Frozen Shoulder Syndrome
6. FDA Approves First Generic Version of Cholesterol-Lowering Drug Lipitor
7. Philips MicroDose Next Generation Mammography Solution Gains Traction with First North American Customers, Enabling Excellent Image Quality at a Low Radiation Dose
8. Uptake Medical Announces First Commercial Use of InterVapor for Patients With Severe Emphysema
9. Odyssey Thera is First to Install Next Generation High-Content Imaging Capability
10. China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2012
11. Samplify Systems Announces Availability of First Ultrasound Beamforming ASIC For Merchant Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014 PuraMed BioScience ® , Inc., ... (OTC) medicinal and healthcare products, announced today that ... along with the name,s red and yellow logo. ... name MigraPure ®  going forward. The new ... natural migraine pain reliever will be reintroduced into ...
(Date:7/30/2014)... Research and Markets has announced the addition ... 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... at a lower CAGR in developed countries; however, it is expected ... China , India , and ... growth of the hematology analyzers and reagents market is driven by ...
(Date:7/30/2014)... , July 30, 2014  Today the US Surgeon ... and outdoor sun tanning or sun burns stating they can ... Surgeon, General Boris Lushniak , says that "skin cancer ... and that too much exposure to indoor and outdoor ultraviolet ... Dermatology and Aesthetic Medicine, in Boca Raton, Florida ...
Breaking Medicine Technology:PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 2PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 3Hematology Analyzers & Reagents Market - Forecasts to 2019 2Indoor and Outdoor Sun Tanning or Sun Burns Directly Linked to Deadly Melanoma Skin Cancer 2
(Date:7/30/2014)... 2014 2014 Deep Research ... is a professional and in-depth research report ... provides basic Chitosan information, including Chitosan definition, ... well as industry overview. This research covers ... as well as global industry analysis covering ...
(Date:7/30/2014)... July 30, 2014 Frozen shoulder (Adhesive capsulitis) ... likely to develop this nasty condition which occurs most frequently ... can last up to two and half years if not ... shoulder, and with good reason: it can render your shoulder ... that is, if you aren't in too much pain to ...
(Date:7/30/2014)... July 30, 2014 The report "Peracetic ... by Application (Healthcare, Food, Water Treatment, Pulp & Paper, ... ROW) - Global Trends & Forecasts to 2018". Peracetic ... of 229.54 kilotons by 2019, signifying a robust growth ... , Browse 83 market data tables and 33 figures ...
(Date:7/30/2014)... For patients with asthma, just believing an odor is ... at least 24 hours, a new study indicates. ... you think you smell," study author Cristina Jaen, a ... in a Monell news release. "Asthmatics often ... that an odor is harmful, our bodies react as ...
(Date:7/30/2014)... Amy Norton HealthDay Reporter ... in a garden might help soothe the agitation that commonly ... at 17 past studies, British researchers found evidence that watering ... soothe some dementia patients, anxiety. The study authors cautioned ... tough subject to study -- and the evidence of a ...
Breaking Medicine News(10 mins):Health News:Chitosan Market & Sialic Acid Industry Research Analysis for World, China Regions Available at DeepResearchReports.com 2Health News:Chitosan Market & Sialic Acid Industry Research Analysis for World, China Regions Available at DeepResearchReports.com 3Health News:Chitosan Market & Sialic Acid Industry Research Analysis for World, China Regions Available at DeepResearchReports.com 4Health News:Good News for Diabetics Suffering from Frozen Shoulder 2Health News:Good News for Diabetics Suffering from Frozen Shoulder 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 4Health News:Peracetic Acid Market Worth $664.24 Million by 2018 – New Report by MarketsandMarkets 2Health News:Peracetic Acid Market Worth $664.24 Million by 2018 – New Report by MarketsandMarkets 3Health News:Peracetic Acid Market Worth $664.24 Million by 2018 – New Report by MarketsandMarkets 4Health News:Even Thinking an Odor is Harmful May Spur Asthma Symptoms 2Health News:Gardens a Center of Calm for People With Dementia 2Health News:Gardens a Center of Calm for People With Dementia 3
... service to new or existing customers., BOTHELL, ... CSCX ) announced today that it has initiated ... external,defibrillators (AEDs) manufactured between August 2006 and March ... have a component whose performance,doesn,t match the factory ...
... 2008 The AMERIGROUP Foundation,today announced a contribution ... Intelligence (SCHI) to enhance the organization,s vocational,training program., ... specifically educates,multiply handicapped, underprivileged children with special needs ... and alleviate the suffering of the,most vulnerable members ...
... ) announced today that the expanded clinical evaluation of its ReValving ... aortic stenosis continues to enroll patients at an accelerating pace. More ... centers in 20 countries. , ... IRVINE, Calif. ...
... Pri-Med New York,conference at the Jacob K. Javits ... prepared by MTBC, the innovative healthcare IT,company based ... of medical,billing, claims submission, reimbursement, EMR software, and ... scored less than 50%. The average number,of correct ...
... VIEW, Calif., Oct. 13 Based on its ... Sullivan recognizes,Infor-Med, Inc. with the 2008 North American ... novel Praxis(R) Electronic Medical Records,(EMR) version 4, featuring ... EMR system employs a unique technology that does ...
... call center based in the Dallas/Ft. Worth Metroplex,was included ... companies,in the country for the second straight year. Beryl ... last five years., The Inc. 5000 list is ... the economy - America,s independent-minded entrepreneurs. Taken,as a whole, ...
Cached Medicine News:Health News:Cardiac Science Initiates Voluntary Field Corrective Action of Certain AEDs 2Health News:Cardiac Science Initiates Voluntary Field Corrective Action of Certain AEDs 3Health News:AMERIGROUP Foundation Supports the School for Children with Hidden Intelligence 2Health News: CoreValve Announces That More Than 1,800 High-Risk Patients Have Been Treated with its ReValving System for Percutaneous Aortic Valve Replacement (PAVR) : Highly encouraging registry data also presented at TCT 2008 2Health News:MTBC Practice Management Quiz Sends Message to Doctors: There is Real Room for Improvement or a Need to Outsource 2Health News:Frost & Sullivan Awards Infor-Med for its Electronic Medical Record Technology 2Health News:Frost & Sullivan Awards Infor-Med for its Electronic Medical Record Technology 3Health News:The Beryl Companies Named to Inc. 5000 List for Second Consecutive Year 2
... The UST-9121 is an ... sector transducer with a wide ... frequencies, this transducer is designed ... an intercostal window. The versatility ...
... transducer is a curved ... the higher frequencies. Featuring ... this transducer provides exceptional ... frequency abdominal kidney bladder ...
... to Enzo Clinical Labs, a full service ... the leading regional labs in the country, ... of a large laboratory with the convenience ... Enzo was one of the area's first ...
... Test System* is a multiplexed, fluorescent, ... multiple assays from a single sample ... a simple and streamlined alternative to ... clinical sensitivity and comparable clinical specificity ...
Medicine Products: